Chuang-Ming Zheng

6PUBLICATIONS
19CO-AUTHORS
Microbial geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 02, 2025
Optimizing extraction of microbial DNA from urine: Advancing urinary microbiome research in bladder cancer.

Chuang-Ming Zheng, Ho Won Kang, Seongmin Moon

|Oct 26, 2024
Differential Urinary Microbiome and Its Metabolic Footprint in Bladder Cancer Patients Following BCG Treatment.

Kyungchan Min, Chuang-Ming Zheng, Sujeong Kim

|Jan 10, 2024
COL6A1 expression as a potential prognostic biomarker for risk stratification of T1 high grade bladder cancer: Unveiling the aggressive nature of a distinct non-muscle invasive subtype.

Kyeong Kim, Young Joon Byun, Chuang-Ming Zheng

|Feb 11, 2023
A New Treatment Landscape for RCC: Association of the Human Microbiome with Improved Outcomes in RCC.

Xuan-Mei Piao, Young Joon Byun, Chuang-Ming Zheng

|Nov 26, 2022
Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk Groups.

Xuan-Mei Piao, Seon-Kyu Kim, Young Joon Byun

|Mar 04, 2022
Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zone.

Ho Won Kang, Young Joon Byun, Sung Min Moon

Pageof 1

Frequent Collaborators

6 joint publications

Xuan-Mei Piao

6 joint publications

Seok Joong Yun

4 joint publications

Yung Hyun Choi

3 joint publications

Ho Won Kang